The incidence of inflammatory lung diseases such as acute respiratory distress syndrome (ARDS) remains an important problem, particularly in the present time with the Covid-19 pandemic. However, an adequate in vitro test system to monitor the barrier function of the alveolar epithelium during inflammation and for assessing anti-inflammatory drugs is urgently needed. Therefore, we treated human Alveolar Epithelial Lentivirus-immortalised cells (hAELVi cells) with the pro-inflammatory cytokines TNF-α (25 ng/ml) and IFN-γ (30 ng/ml), in the presence or absence of hydrocortisone (HC). While TNF-α and IFN-γ are known to reduce epithelial barrier properties, HC could be expected to protect the barrier function and result in an anti-inflammatory effect. We investigated the impact of anti-inflammatory/inflammatory treatment on transepithelial electrical resistance (TEER) and the apparent permeability coefficient (Papp) of the low permeability marker sodium fluorescein (NaFlu). After incubating hAELVi cells for 48 hours with a combination of TNF-α and IFN-γ, there was a significant decrease in TEER and a significant increase in the Papp. The presence of HC maintained the TEER values and barrier properties, so that no significant Papp change was observed. By using hAELVi cells to study anti-inflammatory drugs in vitro, the need for animal experiments could be reduced and pulmonary drug development accelerated.
YouakimAAhdiehM. Interferon-γ decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am J Physiol Liver Physiol2017; 276: G1279–G1288.
19.
ProudfootAGMcAuleyDFGriffithsMJD, et al.Human models of acute lung injury. Dis Model Mech2011; 4: 145–153.
Matute-BelloGFrevertCWMartinTR. Animal models of acute lung injury. Am J Physiol Cell Mol Physiol2008; 295: L379–L399.
22.
GordonSDaneshianMBouwstraJ, et al.Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology. ALTEX2015; 32: 327–378.
23.
WangLTanejaRWangW, et al.Human alveolar epithelial cells attenuate pulmonary microvascular endothelial cell permeability under septic conditions. PLoS One2013; 8: e55311.
24.
RenHBirchNPSureshV. An optimised human cell culture model for alveolar epithelial transport. PLoS One2016; 11: 1–22.
25.
DraslerBKarakocakBBTankusEB, et al.An inflamed human alveolar model for testing the efficiency of anti-inflammatory drugs in vitro. Front Bioeng Biotechnol2020; 8: 1–21.
26.
CastellaniSDi GioiaSdi TomaL, et al.Human cellular models for the investigation of lung inflammation and mucus production in cystic fibrosis. Anal Cell Pathol2018; 15: Article ID 3839803.
27.
JunaidAMashaghiAHankemeierT, et al.An end-user perspective on organ-on-a-chip: assays and usability aspects. Curr Opin Biomed Eng2017; 1: 15–22.
28.
Balogh SivarsKSivarsUHornbergE, et al.A 3D human airway model enables prediction of respiratory toxicity of inhaled drugs in vitro. Toxicol Sci2018; 162: 301–308.
29.
NeilsonLMankusCThorneD, et al.Development of an in vitro cytotoxicity model for aerosol exposure using 3D reconstructed human airway tissue; application for assessment of e-cigarette aerosol. Toxicol In Vitro2015; 29: 1952–1962.
30.
BarosovaHMaioneAGSeptiadiD, et al.Use of EpiAlveolar lung model to predict fibrotic potential of multiwalled carbon nanotubes. ACS Nano2020; 14: 3941–3956.
31.
ZscheppangKBergJHedtrichS, et al.Human pulmonary 3D models for translational research. Biotechnol J2018; 13: 1–12.
32.
HittingerMMellNAHuwerH, et al.Autologous co-culture of primary human alveolar macrophages and epithelial cells for investigating aerosol medicines. Part II: evaluation of IL-10-loaded microparticles for the treatment of lung inflammation. Altern Lab Anim2016; 44: 349–360.
33.
KuehnAKlettingSDe Souza Carvalho-WodarzC, et al.Human alveolar epithelial cells expressing tight junctions to model the air–blood barrier. ALTEX2016; 33: 251–260.
SrinivasanBKolliAREschMB, et al.TEER measurement techniques for in vitro barrier model systems. J Lab Autom2015; 20: 107–126.
36.
ElbertKJSchäferUFSchäfersHJ, et al.Monolayers of human alveolar epithelial cells in primary culture for pulmonary absorption and transport studies. Pharm Res1999; 16: 601–608.
37.
MolendaNUrbanovaKWeiserN, et al.Paracellular transport through healthy and cystic fibrosis bronchial epithelial cell lines — Do we have a proper model?PLoS One2014; 9: e100621.
38.
GaillardPJDe BoerAG. Relationship between permeability status of the blood–brain barrier and in vitro permeability coefficient of a drug. Eur J Pharm Sci2000; 12: 95–102.
39.
DörfelMJHuberO. Modulation of tight junction structure and function by kinases and phosphatases targeting occludin. J Biomed Biotechnol2012; 2012: 303–313.
40.
FaverioPDe GiacomiFSardellaL, et al.Management of acute respiratory failure in interstitial lung diseases: overview and clinical insights. BMC Pulm Med2018; 18: 1–13.
41.
KojicicMFesticEGajicO. Acute respiratory distress syndrome: insights gained from clinical and translational research. Bosn J Basic Med Sci2009; 9: S59–S68.
42.
MatthayMAFolkessonHGClericiC. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev2002; 82: 569–600.
43.
ZemansRLMatthayMA. Bench-to-bedside review: the role of the alveolar epithelium in the resolution of pulmonary edema in acute lung injury. Crit Care2004; 8: 469–477.
44.
OhtaHChibaSEbinaM, et al.Altered expression of tight junction molecules in alveolar septa in lung injury and fibrosis. Am J Physiol Lung Cell Mol Physiol2012; 302: 193–205.
45.
HeroldSMayerKLohmeyerJ. Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair. Front Immunol2011; 2: 1–13.
46.
GrommesJSoehnleinO. Contribution of neutrophils to acute lung injury. Mol Med2011; 17: 293–307.
47.
DeliMA. Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. Biochim Biophys Acta Biomembr2009; 1788: 892–910.
48.
LinnankoskiJMäkeläJPalmgrenJ, et al.Paracellular porosity and pore size of the human intestinal epithelium in tissue and cell culture models. J Pharm Sci2010; 99: 2166–2175.
49.
MukhopadhyaySHoidalJRMukherjeeTK. Role of TNFα in pulmonary pathophysiology. Respir Res2006; 7: 1–9.
50.
MaTYIwamotoGKHoaNT, et al.TNF-α-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation. Am J Physiol2011; 1: 367–376.
51.
MoldoveanuBOtmishiPJaniP, et al.Inflammatory mechanisms in the lung. J Inflamm2009; 2: 1–11.
52.
CuiWLiLXSunCM, et al.Tumor necrosis factor alpha increases epithelial barrier permeability by disrupting tight junctions in Caco-2 cells. Braz J Med Biol Res2010; 43: 330–337.
53.
ParkWYGoodmanRBSteinbergKP, et al.Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med2001; 164: 1896–1903.
54.
MashukovaAWaldFASalasPJ. Tumor necrosis factor alpha and inflammation disrupt the polarity complex in intestinal epithelial cells by a posttranslational mechanism. Mol Cell Biol2011; 31: 756–765.
55.
MaTYBoivinMAYeD, et al.Mechanism of TNF-α modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol2005; 288: 422–430.
56.
Al-SadiRBoivinMMaT. Mechanism of cytokine modulation of epithelial tight junction barrier. Front Biosci2009; 14: 2765–2778.
57.
JulianMWBaoSKnoellDL, et al.Intestinal epithelium is more susceptible to cytopathic injury and altered permeability than the lung epithelium in the context of acute sepsis. Int J Exp Pathol2011; 92: 366–376.
58.
BoivinMARoyPKBradleyA, et al.Mechanism of interferon-γ-induced increase in T84 intestinal epithelial tight junction. J Interf Cytokine Res2009; 29: 45–54.
59.
LiuBBaoLLWangL, et al.Anti-IFN-γ therapy alleviates acute lung injury induced by severe influenza A (H1N1) pdm09 infection in mice. J Microbiol Immunol Infect. 2019; S1684–1182(18): 30438–30439. DOI: 10.1016/j.jmii.2019.07.009.
60.
ZhangYLiJZhanY, et al.Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect Immun2004; 72: 4410–4415.
61.
WatsonCJHoareCJGarrodDR, et al.Interferon-γ selectively increases epithelial permeability to large molecules by activating different populations of paracellular pores. J Cell Sci2005; 118: 5221–5230.
62.
AndrewsCMcLeanMHDurumSK. Cytokine tuning of intestinal epithelial function. Front Immunol2018; 9: 1270.
63.
YangSYuMSunL, et al.Interferon-γ-induced intestinal epithelial barrier dysfunction by NF-κB/HIF-1α pathway. J Interf Cytok Res2014; 34: 195–203.
64.
PetecchiaLSabatiniFUsaiC, et al.Cytokines induce tight junction disassembly in airway cells via an EGFR-dependent MAPK/ERK1/2-pathway. Lab Invest2012; 92: 1140–1148.
65.
CoyneCBVanhookMKGamblingTM, et al.Regulation of airway tight junctions by proinflammatory cytokines. Mol Biol Cell2002; 13: 4100–4109.
66.
PohlCHermannsMIUboldiC, et al.Barrier functions and paracellular integrity in human cell culture models of the proximal respiratory unit. Eur J Pharm Biopharm2009; 72: 339–349.
67.
EhrhardtCKneuerCFiegelJ, et al.Influence of apical fluid volume on the development of functional intercellular junctions in the human epithelial cell line 16HBE14o-: implications for the use of this cell line as an in vitro model for bronchial drug absorption studies. Cell Tissue Res2002; 308: 391–400.
68.
BurMHuwerHLehrCM, et al.Assessment of transport rates of proteins and peptides across primary human alveolar epithelial cell monolayers. Eur J Pharm Sci2006; 28: 196–203.
69.
BaichwalVRBaeuerlePA.Apoptosis: Activate NF-κB or die?Curr Biol1997; 7: 94–96.
70.
LeeKSChoiYHKimYS, et al.Evaluation of bronchoalveolar lavage fluid from ARDS patients with regard to apoptosis. Respir Med2008; 102: 464–469.
71.
NakamuraMMatute-BelloGLilesWC, et al.Differential response of human lung epithelial cells to Fas-induced apoptosis. Am J Pathol2004; 164: 1949–1958.
72.
OssinaNKCannasAPowersVC, et al.Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem1997; 272: 16351–16357.
73.
WrightKKoliosGWestwickJ, et al.Cytokine-induced apoptosis in epithelial HT-29 cells is independent of nitric oxide formation. Evidence for an interleukin-13-driven phosphatidylinositol 3-kinase-dependent survival mechanism. J Biol Chem1999; 274: 17193–17201.
74.
BegueBWajantHBambouJC, et al.Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions. Gastroenterol2006; 130: 1962–1974.
75.
BraithwaiteATMarriottHMLawrieA. Divergent roles for TRAIL in lung diseases. Front Med2018; 5: 1–8.
76.
GstraunthalerGLindlTVan Der ValkJ. A plea to reduce or replace fetal bovine serum in cell culture media. Cytotechnology2013; 65: 791–793.
77.
RussellWMSBurchRL. The principles of humane experimental technique. London: Methuen, 1959, 238 pp.
78.
RosnerBACristofaloVJ. Hydrocortisone: a specific modulator of in vitro cell proliferation and aging. Mech Ageing Dev1979; 9: 485–496.
79.
FörsterCBurekMRomeroIA, et al.Differential effects of hydrocortisone and TNFα on tight junction proteins in an in vitro model of the human blood–brain barrier. J Physiol2008; 586: 1937–1949.
80.
FörsterCKahlesTKietzS, et al.Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND. J Physiol2007; 580: 937–949.
81.
BlecharzKGDrenckhahnDFörsterCY. Glucocorticoids increase VE-cadherin expression and cause cytoskeletal rearrangements in murine brain endothelial cEND cells. J Cereb Blood Flow Metab2008; 28: 1139–1149.
82.
The RECOVERY Collaborative Group. Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report. N Engl J Med2020, Published online 17 Jul 2020. DOI: 10.1056/NEJMoa2021436.
83.
ShulerLHickmanJJ. TEER measurement techniques for in vitro barrier model systems. J Lab Autom2015; 20: 107–126.
84.
ChenSEinspanierRSchoenJ. Transepithelial electrical resistance (TEER): a functional parameter to monitor the quality of oviduct epithelial cells cultured on filter supports. Histochem Cell Biol2015; 144: 509–515.
85.
KielgastFSchmidtHBraubachP, et al.Glucocorticoids regulate tight junction permeability of lung epithelia by modulating claudin 8. Am J Respir Cell Mol Biol2016; 54: 707–717.
86.
PatelVJBiswas RoySMehtaHJ, et al.Alternative and natural therapies for acute lung injury and acute respiratory distress syndrome. Biomed Res Int2018; 2018: 2476824.
87.
KlettingSBartholdSRepnikU, et al.Co-culture of human alveolar epithelial (hAELVi) and macrophage (THP-1) cell lines. ALTEX2018; 35: 211–222.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
